SG11201505389WA - Process for preparing the anti-tumor agent 6-(7-((1-aminocyclopropyl) methoxy)-6-methoxyquinolin-4-yloxy)-n-methyl-1-naphthamide and its crystalline - Google Patents
Process for preparing the anti-tumor agent 6-(7-((1-aminocyclopropyl) methoxy)-6-methoxyquinolin-4-yloxy)-n-methyl-1-naphthamide and its crystallineInfo
- Publication number
- SG11201505389WA SG11201505389WA SG11201505389WA SG11201505389WA SG11201505389WA SG 11201505389W A SG11201505389W A SG 11201505389WA SG 11201505389W A SG11201505389W A SG 11201505389WA SG 11201505389W A SG11201505389W A SG 11201505389WA SG 11201505389W A SG11201505389W A SG 11201505389WA
- Authority
- SG
- Singapore
- Prior art keywords
- aminocyclopropyl
- naphthamide
- methoxyquinolin
- yloxy
- methoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C269/06—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/24—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/26—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
- C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
- C07C309/66—Methanesulfonates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epidemiology (AREA)
- Quinoline Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361754516P | 2013-01-18 | 2013-01-18 | |
| PCT/US2014/011948 WO2014113616A1 (en) | 2013-01-18 | 2014-01-17 | Process for preparing the anti-tumor agent 6-(7-((1-aminocyclopropyl) methoxy)-6-methoxyquinolin-4-yloxy)-n-methyl-1-naphthamide and its crystalline |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201505389WA true SG11201505389WA (en) | 2015-08-28 |
Family
ID=51210076
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201505389WA SG11201505389WA (en) | 2013-01-18 | 2014-01-17 | Process for preparing the anti-tumor agent 6-(7-((1-aminocyclopropyl) methoxy)-6-methoxyquinolin-4-yloxy)-n-methyl-1-naphthamide and its crystalline |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US9783498B2 (en) |
| EP (1) | EP2945931A4 (en) |
| JP (1) | JP2016506917A (en) |
| KR (1) | KR102275034B1 (en) |
| CN (2) | CN111454206A (en) |
| AU (1) | AU2014207482A1 (en) |
| BR (1) | BR112015017100A2 (en) |
| CA (1) | CA2896898A1 (en) |
| EA (1) | EA201591205A1 (en) |
| HK (2) | HK1213563A1 (en) |
| IL (1) | IL239877B (en) |
| MA (1) | MA38274A1 (en) |
| MX (1) | MX2015008543A (en) |
| PH (1) | PH12015501571A1 (en) |
| RU (1) | RU2015127211A (en) |
| SG (1) | SG11201505389WA (en) |
| WO (1) | WO2014113616A1 (en) |
| ZA (1) | ZA201505043B (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105311029A (en) | 2014-06-06 | 2016-02-10 | 正大天晴药业集团股份有限公司 | Antineoplastic-activity quinoline derivative |
| CN105311030B (en) | 2014-06-06 | 2020-03-24 | 正大天晴药业集团股份有限公司 | Anti-tumor spiro-substituted compound |
| WO2016010869A2 (en) | 2014-07-14 | 2016-01-21 | Advenchen Pharmaceuticals, LLC | FUSED QUINOLINE COMPUNDS AS PI3K, mTOR INHIBITORS |
| ES2793286T3 (en) | 2014-12-09 | 2020-11-13 | Chai Tai Tianqing Pharmaceutical Group Co Ltd | Quinoline derivative against non-small cell lung carcinoma |
| US9751859B2 (en) * | 2015-05-04 | 2017-09-05 | Advenchen Pharmaceuticals, LLC | Process for preparing an anti-cancer agent, 1-((4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)methyl)cyclopropanamine, its crystalline form and its salts |
| JP6913955B2 (en) | 2015-07-11 | 2021-08-04 | アドヴェンチェン ファーマスーティカルズ，エルエルシー | Molten quinoline compound as PI3K / mTOR inhibitor |
| CN107296811B (en) | 2016-04-15 | 2022-12-30 | 正大天晴药业集团股份有限公司 | Quinoline derivative for treating gastric cancer |
| EP4279138A3 (en) | 2018-03-02 | 2024-03-27 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Crystal of compound as c-met kinase inhibitor and preparation method therefor and use thereof |
| CN110483393A (en) * | 2018-05-14 | 2019-11-22 | 上海海和药物研究开发有限公司 | The vertical crystal form for Buddhist nun of moral |
| CN110483392A (en) * | 2018-05-14 | 2019-11-22 | 上海海和药物研究开发有限公司 | Synthesize the method and synthetic intermediate of the quinoline -7- base oxygroup methylcyclopropyl groups amine derivative of N-protected |
| CN115160221A (en) * | 2022-07-26 | 2022-10-11 | 上海歆贻医药科技有限公司 | Delitinib crystal form compound and application |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8163923B2 (en) * | 2007-03-14 | 2012-04-24 | Advenchen Laboratories, Llc | Spiro substituted compounds as angiogenesis inhibitors |
| US8148532B2 (en) * | 2007-03-14 | 2012-04-03 | Guoqing Paul Chen | Spiro substituted compounds as angiogenesis inhibitors |
| IT1393351B1 (en) * | 2009-03-16 | 2012-04-20 | Eos Ethical Oncology Science Spa In Forma Abbreviata Eos Spa | PROCEDURE FOR THE PREPARATION OF 6- (7 - ((1-AMINOCYCLOPROPYL) METHOSSI) -6-METOSSICHINOLIN-4-ILOSSI) -N-METHYL-1-NAFTAMIDE AND ITS INTERMEDIATES OF SYNTHESIS |
| US8664244B2 (en) * | 2010-09-12 | 2014-03-04 | Advenchen Pharmaceuticals, LLC | Compounds as c-Met kinase inhibitors |
| CN104023715B (en) * | 2011-12-02 | 2016-10-26 | Ea制药株式会社 | The side effect depressant of inhibitors of kinases |
| KR20150083117A (en) * | 2012-11-08 | 2015-07-16 | 클리어사이드 바이오메디컬, 인코포레이드 | Methods and devices for the treatment of ocular disease in human subjects |
-
2014
- 2014-01-17 JP JP2015553837A patent/JP2016506917A/en active Pending
- 2014-01-17 SG SG11201505389WA patent/SG11201505389WA/en unknown
- 2014-01-17 BR BR112015017100A patent/BR112015017100A2/en not_active IP Right Cessation
- 2014-01-17 EA EA201591205A patent/EA201591205A1/en unknown
- 2014-01-17 AU AU2014207482A patent/AU2014207482A1/en not_active Abandoned
- 2014-01-17 MA MA38274A patent/MA38274A1/en unknown
- 2014-01-17 WO PCT/US2014/011948 patent/WO2014113616A1/en active Application Filing
- 2014-01-17 KR KR1020157021964A patent/KR102275034B1/en active IP Right Grant
- 2014-01-17 US US14/760,549 patent/US9783498B2/en active Active
- 2014-01-17 MX MX2015008543A patent/MX2015008543A/en unknown
- 2014-01-17 CN CN202010295470.0A patent/CN111454206A/en active Pending
- 2014-01-17 RU RU2015127211A patent/RU2015127211A/en unknown
- 2014-01-17 CA CA2896898A patent/CA2896898A1/en active Pending
- 2014-01-17 EP EP14740190.5A patent/EP2945931A4/en not_active Withdrawn
- 2014-01-17 CN CN201480005301.1A patent/CN104936946A/en active Pending
-
2015
- 2015-07-09 IL IL239877A patent/IL239877B/en not_active IP Right Cessation
- 2015-07-14 ZA ZA2015/05043A patent/ZA201505043B/en unknown
- 2015-07-15 PH PH12015501571A patent/PH12015501571A1/en unknown
-
2016
- 2016-02-11 HK HK16101503.0A patent/HK1213563A1/en unknown
- 2016-05-10 HK HK16105284.6A patent/HK1217328A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1213563A1 (en) | 2016-07-08 |
| BR112015017100A2 (en) | 2017-07-11 |
| IL239877A0 (en) | 2015-08-31 |
| ZA201505043B (en) | 2017-11-29 |
| CN104936946A (en) | 2015-09-23 |
| PH12015501571A1 (en) | 2015-10-05 |
| HK1217328A1 (en) | 2017-01-06 |
| US9783498B2 (en) | 2017-10-10 |
| CN111454206A (en) | 2020-07-28 |
| RU2015127211A (en) | 2017-03-03 |
| KR20150108871A (en) | 2015-09-30 |
| WO2014113616A1 (en) | 2014-07-24 |
| AU2014207482A1 (en) | 2015-08-13 |
| JP2016506917A (en) | 2016-03-07 |
| MA38274A1 (en) | 2017-02-28 |
| IL239877B (en) | 2018-07-31 |
| KR102275034B1 (en) | 2021-07-12 |
| CA2896898A1 (en) | 2014-07-24 |
| MX2015008543A (en) | 2015-11-16 |
| EP2945931A4 (en) | 2016-10-12 |
| EP2945931A1 (en) | 2015-11-25 |
| EA201591205A1 (en) | 2015-12-30 |
| US20150353496A1 (en) | 2015-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201505043B (en) | Process for preparing the anti-tumor agent 6-(7-((1-aminocyclopropyl) methoxy)-6-methoxyquinolin-4-yloxy)-n-methyl-1-naphthamide and its crystalline | |
| HK1224334A1 (en) | Compounds for inducing anti-tumor immunity and methods thereof | |
| IL243207B (en) | Process for manufacturing 4 -propargylated amino-benzoxazinones | |
| EP2966119A4 (en) | Method for manufacturing foamed polypropylene-resin particles | |
| PL2986153T3 (en) | Process and system for preparing dry milk formulae | |
| SG2014014567A (en) | Process for preparing polyether polyols | |
| PL2988604T3 (en) | Process and system for preparing dry milk formulae | |
| HK1207820A1 (en) | Composition for manufacturing adjuvant for cancer patient receiving chemotherapy | |
| IL245474B (en) | Process for the preparation of 5-fluoro-1h-pyrazoles | |
| ZA201509017B (en) | Pcd elements and process for making the same | |
| IL245476A0 (en) | Process for the preparation of 5-fluoro-1h-pyrazoles | |
| EP2970037A4 (en) | Methods for preparing alkylfurans | |
| HUE040552T2 (en) | Method for the preparation of especially pure tdi trimerisates | |
| EP2803423C0 (en) | Copper tube for the construction industry and process for preparing it | |
| SG11201803278VA (en) | Anti-allergic agent for infants | |
| IL243455B (en) | Process for preparing fluoxastrobin | |
| HK1212353A1 (en) | Method for preparing coumestrol or coumestrin | |
| HUE040536T2 (en) | Process for the preparation of halogen-n, n-dimethylbenzylamines | |
| IL229326A (en) | Process for the preparation of n-iodoamides | |
| HK1218755A1 (en) | Novel biphenyl derivative and method for preparing same | |
| IL242897A0 (en) | Process for preparing pyridylpyrazole compounds and derivatives thereof from pyridylhydrazine | |
| PL3087039T3 (en) | Process for the manufacture of glass elements | |
| EP3052484A4 (en) | Sulfonylindole derivatives and method for preparing the same | |
| EP3026146A4 (en) | METHOD FOR PRODUCING SiC SUBSTRATES | |
| IL242946B (en) | Method and system for preparing substrates before gold-plating |